Skip to content
‹ Back to IndustriesHealthcare

How a Physician Practice Can Be Ready for a Pediatric Medical Emergency

Do you see pediatric patients, or do children often accompany adults to visits at your practice or medical office? Then you very likely will encounter a serious pediatric illness or injury requiring a medical emergency response. Managing a pediatric medical emergency is not the same as treating an adult—types of emergencies and responses can vary in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Do you see pediatric patients, or do children often accompany adults to visits at your practice or medical office? Then you very likely will encounter a serious pediatric illness or injury requiring a medical emergency response.

Managing a pediatric medical emergency is not the same as treating an adult—types of emergencies and responses can vary in specific ways with younger patients. Physician practices must know the differences and be prepared.

Differences between Pediatric, Adult Emergencies

While children experience many of the same common medical emergencies as adults, there are critical differences including higher rates of shock and dehydration, respiratory distress, seizures, infection, and serious trauma among younger patients. One reason: some parents choose to bring a child with a developing health issue to their family doctor rather than the emergency room.

Basic Requirements: A Plan and Child-Specific Supplies

Medical response to children largely follows the protocols—and uses much the same equipment—as for adults. Here are the basic requirements recommended by the American Academy of Pediatrics.

Primarily because they are smaller than adults, children can need medical responses using specialized supplies and administration.

  • For airway and resuscitation Pediatric-sized IV gauges Separate infant and pediatric bag-valve-masks and face masks. While a manually triggered oxygen resuscitator is a positive pressure option for administration to adults, it can deliver an overwhelming tidal volume to pediatric patients and smaller adults. Use a portable cylinder with a child-sized oxygen bag-valve-mask instead.
  • For allergic reactions: Pediatric-dose epinephrine auto injector. (If a pedi auto-injector isn’t available, use an adult auto-injector as last resort.)
  • For medication dosing, use the Broselow tape as a reference. This worldwide-accepted medical aide was developed by noted pediatric emergency care physician Dr. James Broselow, a member of the Banyan Medical Advisory Board.

Developing a Preparedness Plan

In addition to appropriate supplies, make sure you have an appropriate plan of action. The first step is to perform a self-assessment of readiness to respond to the most common medical emergencies. The resulting plans should include procurement and organization of equipment and medications to maintain a child until the arrival of emergency services. The plan also should include a maintenance and replenishment process for the supplies.

Incorporate the STAT KIT® Pedi

Banyan offers a comprehensive way to equip a practice for a pediatric medical emergency. We have collaborated with Dr. Broselow to develop the STAT KIT® Pedi. The kit is organized into three levels, with specific attention to efficient organization of the equipment and medications needed for a pediatric emergency. See a video tour here.

OnTraq Keeps Your Kit Current

The STAT KIT® Pedi includes the OnTraq Medications and Supplies Replenishmentprogram. This free service tracks the expiration dates of emergency medications and supplies in your emergency medical kit or crash cart and prompts replacement shipments prior to their expiration.

About Banyan

Since 1971, Banyan has provided STAT KITs that are trusted by physicians in a range of specialties. We are registered with the FDA, DEA and have Verified-Accredited Wholesale Distribution accreditation from the National Boards of Pharmacy. Consult with a Banyan readiness advisor today by calling 888-782-8548 or emailing us.

Read more at statkit.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512